X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

- test

Study offers fresh insight into racial disparities in prostate cancer

Among patients with metastatic castration‐resistant prostate cancer (mCRPC) receiving abiraterone acetate (Zytiga) plus prednisone, survival outcomes were similar between Black... Read More

Studies spotlight misinformation in YouTube bladder and prostate cancer videos

A massive amount of misinformation and bias is being spread in YouTube videos on bladder and prostate cancer, according to... Read More

Major clinical trial pits proton versus photon radiotherapy in prostate cancer

The national 3000-patient COMPPARE trial, which is examining outcomes with proton versus photon radiotherapy in prostate cancer, continues its robust... Read More

CDC warns incidence of metastatic prostate cancer on the rise

Over the past decade, the incidence of metastatic prostate cancer in the United States has been on the rise, according... Read More